DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Arixtra (Fondaparinux Sodium Injection) - Current Clinical Trials


Arixtra Related Clinical Trials

ARIXTRA Local Study For Registration In China. [Completed]

Study of Arixtra to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy [Terminated]

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer [Completed]

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism [Completed]

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression [Withdrawn]

Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism [Terminated]

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) [Terminated]

The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients [Completed]

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology) [Completed]

Fondaparinux in Critically Ill Patients With Renal Failure [Completed]

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis [Completed]

Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure. [Terminated]

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery [Completed]

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT) [Withdrawn]

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients [Terminated]

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients [Terminated]

The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty [Not yet recruiting]

Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency [Terminated]

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux [Recruiting]

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia [Recruiting]

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers [Completed]

Fondaparinux EU-RMP (Adherence) [Completed]

A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients [Completed]

ARIXTRA® Adherence in SVT Patients. [Completed]

Special Drug Use Investigation (Retrospective) for Arixtra� (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) [Completed]

Hemorrhage Risk Prescribed Arixtra [Completed]

Study to Determine Effective Dosing of Fondaparinux in Obese Persons [Terminated]

"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" [Completed]

Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction [Withdrawn]

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux. [Completed]

Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy [Withdrawn]

A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery [Completed]

Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO) [Completed]

Special Drug Use Investigation for Arixtra� (Fondaparinux) Venous Thromboembolism Treatment [Completed]

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Completed]

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis [Active, not recruiting]

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery [Completed]

Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication [Not yet recruiting]

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Completed]

The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients [Completed]

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) [Completed]

Fondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric Surgery [Completed]

Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients [Completed]

Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures [Recruiting]

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI [Completed]

Michelangelo - Oasis 5 [Completed]

Special Drug Use Investigation for ARIXTRA� (Fondaparinux) Injection [Completed]

Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study [Not yet recruiting]

Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism [Completed]

Pharmacokinetics of Fondaparinux in Patients With Major Orthopedic Surgery [Completed]

Hip Fracture Study of GSK576428 (Fondaparinux Sodium) [Completed]

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II [Completed]

Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux [Terminated]

Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty [Completed]

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery [Completed]

Determination of Residual Anticoagulatory Effects of Fondaparinux [Recruiting]

A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) [Withdrawn]

Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery [Active, not recruiting]

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients [Recruiting]

Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs [Completed]

Registry of Hospitalized Patients Treated With Fondaparinux [Completed]

Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study [Completed]

Xarelto Regulatory Post-Marketing Surveillance [Completed]

EINSTEIN Junior Phase III: Oral Rivaroxaban in Children With Venous Thrombosis [Recruiting]

START-Register: Survey on Anticoagulated Patients Register [Recruiting]

Tranexamic Acid in HIp Fracture Surgery (THIF Study) [Completed]

PENELOPE Observational Study [Withdrawn]

Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism [Recruiting]

Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Completed]

Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE [Recruiting]

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients [Recruiting]

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy [Completed]

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy [Recruiting]

Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction [Completed]

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin. [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017